Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Delcath Systems Inc
DCTHCurrent price
9.23 USD
-0.18 USD (-1.91%)
Last closed
9.41 USD
Company
www.delcath.com
ISIN
US24661P8077
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
309 688 864 USD
Yield for 12 month
+291.10 %
1Y
3Y
5Y
10Y
15Y
DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Address: 1633 Broadway, New York, NY, United States, 10019
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
21.33 USDP/E ratio
–Dividend Yield
–Current Year
+2 065 000 USD
Last Year
+2 719 000 USD
Current Quarter
+9 560 000 USD
Last Quarter
+7 766 000 USD
Current Year
+1 302 000 USD
Last Year
+2 033 000 USD
Current Quarter
+9 560 000 USD
Last Quarter
+6 247 000 USD
Key Figures DCTH
1 year
3 years
5 years
10 years
EBITDA
-35 919 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-81.99 %
PEG Ratio
–
Return On Equity TTM
-478.59 %
Wall Street Target Price
21.33 USD
Revenue TTM
11 878 000 USD
Book Value
0.69 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1468.9 %
Dividend Yield
–
Gross Profit TTM
2 033 000 USD
Earnings per share
-2.52 USD
Diluted Eps TTM
-2.52 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics DCTH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DCTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:700
Payout Ratio
–
Last Split Date
24.12.2019
Dividend Date
24.12.2019
Stock Valuation DCTH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
116.2791
Enterprise Value Revenue
24.8667
Price Sales TTM
26.0725
Enterprise Value EBITDA
-1.9197
Price Book MRQ
73.8763
Financials DCTH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DCTH
For 52 weeks
2.25 USD
12.88 USD
50 Day MA
9.78 USD
Shares Short Prior Month
1 215 245
200 Day MA
7.17 USD
Short Ratio
5.26
Shares Short
1 248 999
Short Percent
4.46 %
BeatStart